Copyright © 2019. Inderes Oy. All rights reserved.
Search

Company pages

Olvi Revenio Group Tikkurila Oriola Orion Ramirent Cramo Stora Enso Neste UPM Kemira Valmet Outokumpu YIT Suominen Fortum Aspo Basware Cargotec Elisa Telia company Uponor Solteq Soprano Caverion Metsä Board QPR Software Huhtamäki Raute Tecnotree Siili Solutions Glaston Enedo Innofactor Bittium Etteplan Nokia TietoEVRY Stockmann Kone Konecranes Metso Outotec Ponsse Wärtsilä Verkkokauppa.com CapMan Taaleri Fiskars Kesko Nokian Renkaat Rapala VMC Sampo Sanoma Citycon Ovaro Kiinteistösijoitus Apetit NoHo Partners Nixu United Bankers Aspocomp Panostaja Comptel Nexstim Scanfil Detection Technology Talenom Martela SRV eQ Finnair Pihlajalinna Avidly Piippo Investors House Hoivatilat Marimekko Privanet Teleste UTG Mixing Group Sotkamo Silver Vaisala Consti Yhtiöt Vincit Heeros Alma Media Neo Industrial Exel Composites Ahlstrom - Munksjö Qt Fondia Remedy Next Games Afarak Group Endomines SSAB B Componenta Dovre Group Elecster Incap Kesla Lassila & Tikanoja Lehto Group Nurminen Logistics Robit Tulikivi Valoe Wulff-Yhtiöt Yleiselektroniikka Atria HKScan Honkarakenne Raisio Saga Furs Biohit Silmäasema Ilkka-Yhtymä Kamux Keskisuomalainen PunaMusta Media Tokmanni Group Viking Line DNA Aktia Nordea Bank Ålandsbanken Sievi Capital Asiakastieto Group Digia Trainers' House SSH Communications Security Digitalist Group F-Secure Evli Pankki Ahola Transport Loudspring EAB Group Herantis Pharma Savo-Solar Rovio Titanium Terveystalo Gofore Efecte Admicom BBS-Bioactive Bone Substitutes Harvia Altia Enersense NCC Group Ericsson Skanska Atlas Copco Intrum H&M Clas Ohlson Autoliv Kojamo Eezy Tallinna Sadam LHV Tallink Tallinna Vesi Arco Vara Baltika Ekspress Grupp Harju Elekter Merko Ehitus Nordecon Olympic Entertainment Group PRFoods Silvano Fashion Group Skano Group Tallinna Kaubamaja Pro Kapital Grupp Trigon Property Development Fellow Finance Nordic ID Viafin Service Rush Factory Oma Säästöpankki Cibus Nordic Real Estate LeadDesk Aallon Group Adapteo Arctic Minerals Relais Group Fodelia Optomed Faron Pharmaceuticals Bonava Essity Lundin Petroleum Svenska Cellulosa AB Gränges Boliden Securitas Bilot International Petroleum Corp. Musti Group Saxlund Group Bublar Group

We did not find this company. Try another name.

Recent updates

User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
Orion
7112 investors follow this company
BUY 38.93 LOWEST 36.93 VOLUME 491 765
SELL 38.99 HIGHEST 39.20 VALUE 18,944 Milj. EUR

Would you like to see our recommendations and target prices?

Luo FREE-tiliOsta PREMIUM-tili

You already have an Inderes account? Log in from here.

Analyytikko

Petri Kajaani
+358 50 527 8680

Upcoming events

28
Apr
Osavuosikatsaukset

Forum

Latest insider trading

Article
Company post
Type: stock_exchange_release
Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer
30.3.
2020

ORION CORPORATION PRESS RELEASE 30 MARCH 2020 at 18.15 EEST             

Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer         

Type: stock_exchange_release
Orion cancels its Annual General Meeting on Wednesday 25 March 2020 and postpones it to a later date
19.3.
2020

ORION CORPORATION STOCK EXCHANGE RELEASE 19 MARCH 2020 at 12.20 EET             
         

Orion cancels its Annual General Meeting on Wednesday 25 March 2020 and postpones it to a later date

Due to the development of the coronavirus situation and the announcements by the Finnish Government, Orion’s Board of Directors has decided to cancel the Annual General Meeting convened for Wednesday 25 March 2020.  

Type: stock_exchange_release
Orion Corporation: Change in Orion Group Executive Management Board as of 1 April 2020
5.3.
2020

ORION CORPORATION       STOCK EXCHANGE RELEASE       5 MARCH 2020 at 10.25 a.m. EET             
         

Orion Corporation: Change in Orion Group Executive Management Board as of 1 April 2020

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Satu Ahomäki
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Satu Ahomäki

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Timo Lappalainen
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Timo Lappalainen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Virve Laitinen
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Virve Laitinen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Liisa Hurme
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 3rd March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Liisa Hurme

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Christer Nordstedt
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 3rd March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Christer Nordstedt

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Markku Huhta-Koivisto
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 3rd March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Markku Huhta-Koivisto

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
Orion Corporation: Managers’ transactions – Olli Huotari
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Olli Huotari

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion

Orion lyhyesti

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.